Emergent BioSolutions
EBS
$2.18
Share price
-4.80%
Change (1 day)
-78.50%
Change (1 year)
Categories
Emergent BioSolutions (EBS) Fails to deliver data
Key failure to deliver metrics for Emergent BioSolutions :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.04 M
- Last 3 months FTD volume: $0.74 M
- Last year FTD volume: $6.58 M
Failures to deliver for Emergent BioSolutions (EBS) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Emergent BioSolutions (EBS) - since 2013
Volume in USD (price x number of shares), data since 2013Emergent BioSolutions (EBS) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.74 M | -90.7% |
| 2023 | $8 M | 209.82% |
| 2022 | $2.58 M | -80.14% |
| 2021 | $13 M | -54.52% |
| 2020 | $28.59 M | 174.75% |
| 2019 | $10.4 M | -22.55% |
| 2018 | $13.43 M | 17.87% |
| 2017 | $11.39 M | 24.65% |
| 2016 | $9.14 M | 50.78% |
| 2015 | $6.06 M | 23.18% |
| 2014 | $4.92 M | 671.04% |
| 2013 | $0.63 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Pfizer PFE | $31.87 M | $0.32 B | 🇺🇸 USA |
 Merck MRK | $8.48 M | $0.18 B | 🇺🇸 USA |
 GlaxoSmithKline GSK | $15.53 M | $26.02 M | 🇬🇧 UK |
 Soligenix SNGX | $1.68 M | $4.27 M | 🇺🇸 USA |
 SIGA Technologies SIGA | $1.13 M | $3.86 M | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.8 M | $3.83 M | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $6.66 M | $42.47 M | 🇮🇱 Israel |